Tarsons Products Past Earnings Performance
Past criteria checks 2/6
Tarsons Products has been growing earnings at an average annual rate of 7.9%, while the Life Sciences industry saw earnings growing at 8.8% annually. Revenues have been growing at an average rate of 8.8% per year. Tarsons Products's return on equity is 9.3%, and it has net margins of 20.2%.
Key information
7.9%
Earnings growth rate
7.0%
EPS growth rate
| Life Sciences Industry Growth | 11.2% |
| Revenue growth rate | 8.8% |
| Return on equity | 9.3% |
| Net Margin | 20.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue Miss: Tarsons Products Limited Fell 7.8% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 18
Tarsons Products Limited (NSE:TARSONS) Analysts Are More Bearish Than They Used To Be
Nov 22Tarsons Products Limited (NSE:TARSONS) Analysts Are More Bearish Than They Used To Be
Aug 17Analysts Have Lowered Expectations For Tarsons Products Limited (NSE:TARSONS) After Its Latest Results
Nov 10Tarsons Products Limited's (NSE:TARSONS) 26% Price Boost Is Out Of Tune With Earnings
Jul 20Tarsons Products Limited (NSE:TARSONS) Shares Could Be 28% Below Their Intrinsic Value Estimate
Jul 05Tarsons Products' (NSE:TARSONS) Promising Earnings May Rest On Soft Foundations
Jun 04Revenue & Expenses BreakdownBeta
How Tarsons Products makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2,727 | 551 | 423 | 0 |
| 30 Sep 23 | 2,723 | 613 | 409 | 0 |
| 30 Jun 23 | 2,772 | 700 | 399 | 0 |
| 31 Mar 23 | 2,832 | 807 | 391 | 0 |
| 31 Dec 22 | 2,887 | 874 | 365 | 0 |
| 30 Sep 22 | 2,981 | 927 | 356 | 0 |
| 30 Jun 22 | 3,029 | 961 | 345 | 0 |
| 31 Mar 22 | 3,008 | 1,007 | 338 | 0 |
| 31 Dec 21 | 2,858 | 948 | 314 | 0 |
| 30 Jun 21 | 2,581 | 867 | 286 | 0 |
| 31 Mar 21 | 2,313 | 689 | 267 | 0 |
| 31 Mar 20 | 1,750 | 385 | 206 | 0 |
| 31 Mar 19 | 1,886 | 399 | 164 | 0 |
Quality Earnings: TARSONS has high quality earnings.
Growing Profit Margin: TARSONS's current net profit margins (20.2%) are lower than last year (30.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: TARSONS's earnings have grown by 7.9% per year over the past 5 years.
Accelerating Growth: TARSONS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TARSONS had negative earnings growth (-36.9%) over the past year, making it difficult to compare to the Life Sciences industry average (-1.4%).
Return on Equity
High ROE: TARSONS's Return on Equity (9.3%) is considered low.